Polycystic Ovary Syndrome: A Contemporary Clinical Approach
Ongoing research is focused on multi-target agonists, oral drugs, and broader therapeutic applications beyond diabetes and obesity, including cardiovascular, kidney, liver, and neurodegenerative conditions
Diabetes 52(2):380386 Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM (2015) Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
Glucagon-like peptide-1 (GLP-1) is an incretin hormone, one of several gut-derived peptides secreted in response to nutrient intake that promote insulin release
Add The New York Post on Google WASHINGTON President Trump announced Thursday that two major pharmaceutical companies will be lowering the cost of popular GLP-1 drugs used to treat diabetes and for weight loss and that the government will, in turn, expand eligibility for Medicare users
Eng began searching for new human hormones by analyzing animal tissues for chemical signals